BioCentury | Apr 25, 2011
Company News

Cardiogenesis, CryoLife deal

...CryoLife said Cardiogenesis did not receive alternative acquisition offers during the 20-day period it was allowed...
...engage third parties. Earlier this month, CryoLife began a previously announced tender offer to acquire Cardiogenesis...
...$22 million. The offer is expected to end on May 2 (see BioCentury, April 11). Cardiogenesis Corp....
BioCentury | Apr 11, 2011
Company News

Cardiogenesis, CryoLife deal

...CryoLife began its previously announced tender offer to acquire Cardiogenesis for $0.46 per share, or about...
...million. The offer will expire at the end of May 2 (see BioCentury, April 4). Cardiogenesis Corp....
BioCentury | Apr 4, 2011
Company News

Cardiogenesis, CryoLife deal

...CryoLife will acquire Cardiogenesis for $0.46 per share, or about $22 million in cash. The price...
...per share, or about $22 million in cash. The price is a 43% premium to Cardiogenesis'...
...sales of $11.3 million. Piper Jaffray advised CryoLife and B. Riley & Co. advised Cardiogenesis. Cardiogenesis Corp....
BioCentury | Dec 7, 1998
Clinical News

CardioGenesis Corp. regulatory update

...University (New York, N.Y.). CGCP has exclusive licenses to the rights held by the universities. CardioGenesis Corp....
BioCentury | Apr 21, 1997
Company News

CardioGenesis Corp., Chiron deal

...ITMR system and also plans to begin U.S. trials of the PMR system this quarter. CardioGenesis Corp....
Items per page:
1 - 5 of 5
BioCentury | Apr 25, 2011
Company News

Cardiogenesis, CryoLife deal

...CryoLife said Cardiogenesis did not receive alternative acquisition offers during the 20-day period it was allowed...
...engage third parties. Earlier this month, CryoLife began a previously announced tender offer to acquire Cardiogenesis...
...$22 million. The offer is expected to end on May 2 (see BioCentury, April 11). Cardiogenesis Corp....
BioCentury | Apr 11, 2011
Company News

Cardiogenesis, CryoLife deal

...CryoLife began its previously announced tender offer to acquire Cardiogenesis for $0.46 per share, or about...
...million. The offer will expire at the end of May 2 (see BioCentury, April 4). Cardiogenesis Corp....
BioCentury | Apr 4, 2011
Company News

Cardiogenesis, CryoLife deal

...CryoLife will acquire Cardiogenesis for $0.46 per share, or about $22 million in cash. The price...
...per share, or about $22 million in cash. The price is a 43% premium to Cardiogenesis'...
...sales of $11.3 million. Piper Jaffray advised CryoLife and B. Riley & Co. advised Cardiogenesis. Cardiogenesis Corp....
BioCentury | Dec 7, 1998
Clinical News

CardioGenesis Corp. regulatory update

...University (New York, N.Y.). CGCP has exclusive licenses to the rights held by the universities. CardioGenesis Corp....
BioCentury | Apr 21, 1997
Company News

CardioGenesis Corp., Chiron deal

...ITMR system and also plans to begin U.S. trials of the PMR system this quarter. CardioGenesis Corp....
Items per page:
1 - 5 of 5